ER CD-LD

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03670953 (ClinicalTrials.gov)	November 6, 2018	12/9/2018	A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Flu ...	A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Ca ...	Parkinson's Disease (Disorder)	Drug: IR CD-LD;Drug: IPX203 ER CD-LD;Other: IPX203 placebo;Other: IR CD-LD placebo	Impax Laboratories, LLC	NULL	Completed	40 Years	N/A	All	631	Phase 3	United States;Czechia;France;Germany;Italy;Poland;Spain;United Kingdom
2	NCT03007888 (ClinicalTrials.gov)	November 14, 2016	6/12/2016	A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Diseas ...	A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in S ...	Advanced Parkinson's Disease	Drug: IR CD-LD;Drug: ER CD-LD	Impax Laboratories, LLC	NULL	Completed	40 Years	100 Years	All	28	Phase 2	United States
3	NCT01411137 (ClinicalTrials.gov)	August 2011	4/8/2011	Carbidopa-Levodopa (CD-LD) ERAlone or in Combination With CD-LDIR to IPX066 Followed by IPX066 Exten ...	An Open Label Conversion Study of Carbidopa-Levodopa (CD-LD) Extended-Release Taken Alone or in Comb ...	Parkinson's Disease	Drug: IPX066	Impax Laboratories, LLC	Michael J. Fox Foundation for Parkinson's Research	Completed	30 Years	N/A	All	43	Phase 3	United States

First Previous1Next Last